Guillain-Barré Syndrome (GBS) is a rare neuromuscular condition that can cause rapid paralysis. Diagnosing GBS is challenging, and misdiagnosis can lead to delayed treatment and potentially long-term ...
MONTREAL — An investigational targeted immunotherapy for Guillain-Barré syndrome (GBS) more than doubled improvement in disability after 8 weeks compared with placebo and showed sustained benefit at ...
ANX005-Treated Patients Demonstrated Faster and More Complete Recovery from Week 1 through Week 26 on Primary and Multiple Pre-Specified Endpoints Two and a Half Times More ANX005-Treated Patients ...
Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that attack ...
LUND, Sweden, May 14, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG ...
Add Yahoo as a preferred source to see more of our stories on Google. Paralytic diseases are spreading in Gaza as an Israeli blockade continues to prevent medicine and food from coming in. Since June, ...
In endemic areas, dengue-related Guillain-Barre syndrome could be a 'substantial and underrecognized component of the ...
Add Yahoo as a preferred source to see more of our stories on Google. Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground. But when he ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results